Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2005 1
2006 1
2007 2
2008 1
2010 2
2011 3
2012 3
2013 4
2014 2
2015 5
2016 3
2017 3
2018 3
2019 1
2020 3
2021 2
2022 1
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for marleen h
Search for Marlene H instead (1 results)
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.
Keyaerts M, Xavier C, Heemskerk J, Devoogdt N, Everaert H, Ackaert C, Vanhoeij M, Duhoux FP, Gevaert T, Simon P, Schallier D, Fontaine C, Vaneycken I, Vanhove C, De Greve J, Lamote J, Caveliers V, Lahoutte T. Keyaerts M, et al. J Nucl Med. 2016 Jan;57(1):27-33. doi: 10.2967/jnumed.115.162024. Epub 2015 Oct 8. J Nucl Med. 2016. PMID: 26449837 Free article. Clinical Trial.
A fast blood clearance was observed, with only 10% of injected activity remaining in the blood at 1 h after injection. Uptake was seen mainly in the kidneys, liver, and intestines. ...
A fast blood clearance was observed, with only 10% of injected activity remaining in the blood at 1 h after injection. Uptake was see …
Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium.
van Dorp W, Mulder RL, Kremer LC, Hudson MM, van den Heuvel-Eibrink MM, van den Berg MH, Levine JM, van Dulmen-den Broeder E, di Iorgi N, Albanese A, Armenian SH, Bhatia S, Constine LS, Corrias A, Deans R, Dirksen U, Gracia CR, Hjorth L, Kroon L, Lambalk CB, Landier W, Levitt G, Leiper A, Meacham L, Mussa A, Neggers SJ, Oeffinger KC, Revelli A, van Santen HM, Skinner R, Toogood A, Wallace WH, Haupt R. van Dorp W, et al. J Clin Oncol. 2016 Oct 1;34(28):3440-50. doi: 10.1200/JCO.2015.64.3288. Epub 2016 Jul 25. J Clin Oncol. 2016. PMID: 27458300 Free PMC article. Review.
Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients.
D'Huyvetter M, Vos J, Caveliers V, Vaneycken I, Heemskerk J, Duhoux FP, Fontaine C, Vanhoeij M, Windhorst AD, Aa FV, Hendrikse NH, Eersels JLE, Everaert H, Gykiere P, Devoogdt N, Raes G, Lahoutte T, Keyaerts M. D'Huyvetter M, et al. J Nucl Med. 2021 Aug 1;62(8):1097-1105. doi: 10.2967/jnumed.120.255679. Epub 2020 Dec 4. J Nucl Med. 2021. PMID: 33277400 Free article.
Planar whole-body imaging was performed at 2 and 24 h after injection. Additional SPECT/CT images were obtained after the whole-body images at 2 and 24 h if there was relevant uptake in known cancer lesions. ...The biologic half-life of (131)I-GMIB-anti-HER2-VHH1 in …
Planar whole-body imaging was performed at 2 and 24 h after injection. Additional SPECT/CT images were obtained after the whole-body …
Efficacy of serology driven "test and treat strategy" for eradication of H. pylori in patients with rheumatic disease in the Netherlands.
de Leest HT, Steen KS, Lems WF, van de Laar MA, Huisman AM, Kadir SW, Houben HH, Kostense PJ, Kuipers EJ, Dijkmans BA, Debets-Ossenkopp YJ. de Leest HT, et al. Eur J Clin Microbiol Infect Dis. 2011 Jul;30(7):903-8. doi: 10.1007/s10096-011-1174-5. Epub 2011 Feb 4. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21293900 Free PMC article. Clinical Trial.
The treatment of choice of H. pylori infections is a 7-day triple-therapy with a proton pump inhibitor (PPI) plus amoxicillin and either clarithromycin or metronidazole, depending on local antibiotic resistance rates. ...In the eradication group 13% (20/152, 95% CI 9-20%) …
The treatment of choice of H. pylori infections is a 7-day triple-therapy with a proton pump inhibitor (PPI) plus amoxicillin and eit …
A three-dimensional digital neurological atlas of the mustached bat (Pteronotus parnellii).
Washington SD, Hamaide J, Jeurissen B, van Steenkiste G, Huysmans T, Sijbers J, Deleye S, Kanwal JS, De Groof G, Liang S, Van Audekerke J, Wenstrup JJ, Van der Linden A, Radtke-Schuller S, Verhoye M. Washington SD, et al. Neuroimage. 2018 Dec;183:300-313. doi: 10.1016/j.neuroimage.2018.08.013. Epub 2018 Aug 10. Neuroimage. 2018. PMID: 30102998 Free PMC article.
Lung MRI and impairment of diaphragmatic function in Pompe disease.
Wens SC, Ciet P, Perez-Rovira A, Logie K, Salamon E, Wielopolski P, de Bruijne M, Kruijshaar ME, Tiddens HA, van Doorn PA, van der Ploeg AT. Wens SC, et al. BMC Pulm Med. 2015 May 6;15:54. doi: 10.1186/s12890-015-0058-3. BMC Pulm Med. 2015. PMID: 25943437 Free PMC article.
An Extended Twin-Pedigree Study of Neuroticism in the Netherlands Twin Register.
Boomsma DI, Helmer Q, Nieuwboer HA, Hottenga JJ, de Moor MH, van den Berg SM, Davies GE, Vink JM, Schouten MJ, Dolan CV, Willemsen G, Bartels M, van Beijsterveldt TCEM, Ligthart L, de Geus EJ. Boomsma DI, et al. Behav Genet. 2018 Jan;48(1):1-11. doi: 10.1007/s10519-017-9872-0. Epub 2017 Oct 17. Behav Genet. 2018. PMID: 29043520 Free PMC article.
37 results